Key facts
- KOTOBUKI Medical’s last known valuation is $9.7M (Aug 2021).
- It has raised $2.4M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Shinkin Capital, REVIC Capital, Gunma Medical-Engineering Collaboration Revitalization Fund, Gunma Regional Advanced Solution Partners, Industrial Collaboration Activation Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for KOTOBUKI Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for KOTOBUKI Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KOTOBUKI Medical
Developer of surgical training tools designed to create a society where everyone can face surgery with peace of mind. The company specializes in making surgical training boxes and is involved in developing simulated organ-versatile training tissue to offer realistic reactions when performing training in procedures such as suturing, ligation, and incision, enabling healthcare professionals to improve their skills in medical procedures.
- Sector
- Healthcare
- HQ
- Yashio, Japan
- Founded
- 2018
- Employees
- 13
- Website
- kotobukimedical.com/
- Ownership
- Privately Held (backing)
KOTOBUKI Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KOTOBUKI Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KOTOBUKI Medical in its N-PORT filings yet. We sweep new filings monthly.